《新股》雙登通過聯交所上市聆訊 料成AIDC配套儲能第一股
雙登集團股份通過聯交所上市聆訊,這意味著雙登可能成為港股人工智能數據中心(AIDC)配套儲能第一股。
雙登是大數據及通信領域能源存儲業務的領先公司,公司專注於設計、研發、製造和銷售儲能電池及系統。截至去年12月底,雙登服務了五家全球十大通信運營商及設備商、近30%全球百大通信運營商及設備商、以及中國五大通信運營商及設備商。
截至今年5月底五個月,公司收入18.67億元人民幣,按年增33.9%;純利按年倒退9.3%至1.27億元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.